Clinical trial
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
NCT03489629 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
- Lead sponsor
- University of North Carolina, Chapel Hill
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 3, 2018
- Completion date
- January 31, 2026
- Enrollment
- 49 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.